Sino Biopharmaceutical Ltd

Common Name

Sino Biopharmaceutical

Country

Hong Kong

Sector

Healthcare

Industry

Biotechnology

Employees

24,379

Ticker

1177

Exchange

HONG KONG EXCHANGES AND CLEARING LTD

Website

www.sinobiopharm.com

Description

Sino Biopharmaceutical Ltd. is a diversified biopharmaceutical enterprise specializing in the research, development, manufacturing, and commercialization of a wide array of pharmaceuticals. The compan... Show more

Financial Statements of Sino Biopharmaceutical

Below are the financial statements of Sino Biopharmaceutical, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of CNY	2024	2023
Non-current assets	—	—
Property, plant and equipment	8,691.38^a	8,080.91^a
Investment properties	269.03^a	289.34^a
Right-of-use assets	1,596.77^a	1,831.25^a
Goodwill	915.69^a	680.45^a
Intangible assets	2,145.28^a	2,228.51^a
Investments in associates and joint ventures	1,620.09^a	12,243.68^a
Equity investments designated at fair value through other comprehensive income	10,911.53^a	1,562.87^a
Financial assets at fair value through profit or loss	4,439.11^a	4,699.7^a
Bank deposit	9,365.81^a	7,312.89^a
Deferred tax assets	516.29^a	567.01^a
Prepayments and other assets	251.77^a	302.67^a
Total non-current assets	40,722.74^a	39,799.29^a
Current assets	—	—
Inventories	2,373.15^a	1,993.47^a
Trade and bills receivables	4,967.56^a	4,510.2^a
Prepayments, other receivables and other assets	2,451.74^a	3,635.63^a
Amounts due from related companies	295.61^a	188.61^a
Equity investments designated at fair value through profit or loss	76.86^a	301.08^a
Financial assets at fair value through profit or loss	4,950.83^a	2,811.96^a
Cash and bank balances	9,569.58^a	9,451.88^a
Assets of a disposal group classified as held for sale	0^a	912.71^a
Total current assets	24,685.33^a	23,805.53^a
Current liabilities	—	—
Trade and bills payables	1,497.46^a	1,334.7^a
Tax payable	318.2^a	271.87^a
Other payables and accruals	10,028.42^a	9,405.59^a
Interest-bearing bank borrowings	7,585.83^a	11,135.94^a
Amounts due to related companies	73.3^a	136.13^a
Lease liabilities	28.33^a	71.49^a
Contingent consideration	8.72^a	12.2^a
Convertible bonds - debt component	16.24^a	0^a
Liabilities directly associated with the assets classified as held for sale	0^a	238.86^a
Total current liabilities	19,556.49^a	22,606.78^a
Net current assets	5,128.84^a	1,198.76^a
Total assets less current liabilities	45,851.58^a	40,998.04^a
Non-current liabilities	—	—
Convertible bonds - debt component	0^a	16.48^a
Deferred government grants	557.92^a	548.27^a
Interest-bearing bank borrowings	1,996.75^a	1,057.94^a
Lease liabilities	83.39^a	298.39^a
Contingent consideration	201.9^a	125.46^a
Deferred tax liabilities	237.55^a	781.54^a
Total non-current liabilities	3,077.51^a	2,828.09^a
Net assets	42,774.07^a	38,169.95^a
Equity attributable to owners of the parent	—	—
Share capital	414.38^a	414.62^a
Treasury shares	-2,974.79^a	-1,769.72^a
Reserves	34,521.19^a	31,829.58^a
Equity	—	—
Non-controlling interests	10,813.28^a	7,695.48^a
Total equity	42,774.07^a	38,169.95^a

Download Data

Verified Sources Behind Sino Biopharmaceutical’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sino Biopharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Sino Biopharmaceutical's Annual Report 2024

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Sino Biopharmaceutical Ltd

Financial Statements of Sino Biopharmaceutical

Verified Sources Behind Sino Biopharmaceutical’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

BeOne Medicines AG

Moderna Inc

Ucb SA

Genmab A/S

BioMarin Pharmaceutical Inc

Bio-Techne Corp